Robert Lintner

Robert Lintner is an accomplished scientist with extensive experience in biotechnology and molecular biology. Currently serving as Principal Scientist II at RAN Biotechnologies since January 2019, Robert focuses on technology, materials, and product development. Prior roles include Scientist at Cogen Therapeutics, Inc., where research centered on droplet microfluidics and single-cell genomics, and Research Scientist at the Broad Institute, contributing to genomic and medical genetics R&D. Education includes a Ph.D. in Molecular Biology/Bacterial Genetics from the University of Toledo College of Medicine and a Graduate Certificate in Bioinformatics and Proteomics/Genomics. Robert has collaborated with prestigious institutions, including Harvard University and the Whitehead Institute, and has a rich background in independent research and technology development.